Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Reclutando
Fase 3
ClinicalTrials.gov
An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer
INTERVENTIONAL
Inicio: 14 de abr de 2024
ID: NCT06312176
Completado
ClinicalTrials.gov
Long-term Safety Follow-up of REMICADE (RESULTS)
OBSERVATIONAL
Inicio: 1 de feb de 2002
ID: NCT00261976
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase III Randomized, Double-Blind Placebo Controlled, Multi-Regional, International Study of Durvalumab in Combination With Gemcitabine Plus Cisplatin Versus Placebo in Combination With Gemcitabine Plus Cisplatin for Patients With First-Line Advanced Biliary Tract Cancers
INTERVENTIONAL
Inicio: 16 de abr de 2019
ID: NCT03875235
Reclutando
Fase 2
ClinicalTrials.gov
An Adaptive Phase 2a/2b, Randomized, Double-Blind, Placebo-Controlled Study of LY3871801 in Adult Participants With Moderately-to-Severely Active Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 23 de may de 2023
ID: NCT05848258
Completado
Fase 4
ClinicalTrials.gov
A 26-week, Randomized, Double Blind, Parallel-group Multicenter Study to Assess the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD
INTERVENTIONAL
Inicio: 20 de nov de 2015
ID: NCT02603393
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
INTERVENTIONAL
Inicio: 12 de abr de 2016
ID: NCT02696798
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Parallel-group Study of Long-term Safety and Efficacy of CNTO 136 (Sirukumab) for Rheumatoid Arthritis in Subjects Completing Treatment in Studies CNTO136ARA3002 (SIRROUND-D) and CNTO136ARA3003 (SIRROUND-T)
INTERVENTIONAL
Inicio: 7 de ago de 2013
ID: NCT01856309
Completado
Fase 2
ClinicalTrials.gov
A Phase I/II, Multicenter, Open-Label, Noncomparative Study of the International Maternal, Pediatric, Adolescent AIDS Clinical Trials (IMPAACT) Group to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Raltegravir (Isentress, MK-0518) in HIV-1 Infected Children and Adolescents
INTERVENTIONAL
Inicio: 17 de sept de 2007
ID: NCT00485264
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Open Label Study of Safety and Efficacy With BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected With Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV)
INTERVENTIONAL
Inicio: 1 de dic de 2011
ID: NCT01471574
Completado
Fase 3
ClinicalTrials.gov
A Multicenter Phase III Randomized Trial Comparing Docetaxel in Combination With Doxorubicin and Cyclophosphamide Versus Doxorubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment of Operable Breast Cancer HER2neu Negative Patients With Positive Axillary Lymph Nodes
INTERVENTIONAL
Inicio: 1 de nov de 2001
ID: NCT00312208
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BMS-817399 in Adults With Active, Moderate to Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate
INTERVENTIONAL
Inicio: 1 de sept de 2011
ID: NCT01404585
Terminado
Fase 3
ClinicalTrials.gov
A 52-week, Randomized, Double-blind, Double-dummy, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg), Parallel Group, Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI add-on to Maintenance Triple Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis.
INTERVENTIONAL
Inicio: 12 de jul de 2021
ID: NCT04636814
Completado
Fase 3
ClinicalTrials.gov
Brightline-4: A Phase III Open-label, Single-arm, Multi-center Study to Assess the Safety and Efficacy of Brigimadlin (BI 907828) Treatment in Patients With Treatment-naïve or Pre-treated Advanced Dedifferentiated Liposarcoma
INTERVENTIONAL
Inicio: 13 de dic de 2023
ID: NCT06058793
Completado
Fase 3
ClinicalTrials.gov
An Open-Label, Randomized, Phase 3 Trial Of Intravenous Temsirolimus (CCI-779) At Two Dose Levels Compared To Investigator's Choice Therapy In Relapsed, Refractory Subjects With Mantle Cell Lymphoma (MCL)
INTERVENTIONAL
Inicio: 1 de may de 2005
ID: NCT00117598
Completado
Fase 3
ClinicalTrials.gov
A Double-Blind, Randomized, Stratified Multi-Center Trial Evaluating Conventional and Double Dose Oseltamivir in the Treatment of Immunocompromised Patients With Influenza
INTERVENTIONAL
Inicio: 4 de feb de 2008
ID: NCT00545532
Completado
Fase 3
ClinicalTrials.gov
A Long-term, Randomized, Double-blind, Multicenter, Parallel-group, Phase III Study Evaluating the Efficacy and Safety of PT027 Compared to PT007 Administered as Needed in Response to Symptoms in Symptomatic Adults and Children 4 Years of Age or Older With Asthma
INTERVENTIONAL
Inicio: 13 de dic de 2018
ID: NCT03769090
Completado
ClinicalTrials.gov
Development and Validation of a Multidimensional System to Dynamically Predict Graft Survival After Kidney Transplantation
OBSERVATIONAL
Inicio: 1 de ene de 2004
ID: NCT04258891
Terminado
ClinicalTrials.gov
Association Between Intra-Operative Cochlear Response Telemetry and Hearing Preservation
INTERVENTIONAL
Inicio: 22 de dic de 2017
ID: NCT03134989
Completado
Fase 2
ClinicalTrials.gov
A Phase II, 6-week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel Group Trial With a Quetiapine Arm to Evaluate the Efficacy, Tolerability and Safety of Oral BI 1358894 in Patients With Major Depressive Disorder With Inadequate Response to Antidepressants.
INTERVENTIONAL
Inicio: 20 de nov de 2020
ID: NCT04521478
Completado
Fase 2
ClinicalTrials.gov
A Phase 2 Study of Nivolumab in Combination With Either Rucaparib, Docetaxel, or Enzalutamide in Men With Castration-resistant Metastatic Prostate Cancer
INTERVENTIONAL
Inicio: 19 de dic de 2017
ID: NCT03338790
Anterior
1
...
426
427
428
...
434
Siguiente
Filtros